3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Interventions
pembrolizumab
248
Nivolumab
144
Cisplatin
138
Cyclophosphamide
137
Paclitaxel
116
Carboplatin
112
Gemcitabine
100
Radiotherapy
86
Dexamethasone
84
Docetaxel
79
Ipilimumab
70
atezolizumab
68
Doxorubicin
63
Fluorouracil
60
Bevacizumab
59
Blood Specimen Collection
58
Etoposide
55
fludarabine
54
Rituximab
54
Oxaliplatin
52
Prednisone
51
Lenalidomide
51
Surveys and Questionnaires
50
Cetuximab
47
Standard of Care
46
Capecitabine
46
Radiosurgery
45
Magnetic Resonance Spectroscopy
45
lenvatinib
43
durvalumab
43
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
romiplostim
×
1 year
×
Clear all
NCT03362177
2026-02-11
RECITE
Amgen
Phase 3
Completed
165 enrolled
22 charts